(1)
ANALYSIS OF LIQUIDITY RATIO, PROFITABILITY,AND SOLVABILITY TO EVALUATE THE PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE (BEI) DURING THE PERIOD 2021-2023. ICEBMR 2024, 3 (1), 457-471. https://doi.org/10.24071/icebmr.v3i1.120.